04069nam 2200661 a 450 991080717040332120240516151550.0978661376995497812809983481280998342978111834785011183478549781118347867111834786297811183478361118347838(CKB)2670000000209398(EBL)894396(OCoLC)798534225(SSID)ssj0000678964(PQKBManifestationID)11396070(PQKBTitleCode)TC0000678964(PQKBWorkID)10737742(PQKB)11365252(MiAaPQ)EBC894396(Au-PeEL)EBL894396(CaPaEBR)ebr10580148(CaONFJC)MIL376995(PPN)178684562(Perlego)1013375(EXLCZ)99267000000020939820120117d2012 uy 0engur|n|---|||||txtccrResolving erroneous reports in toxicology and therapeutic drug monitoring a comprehensive guide /Amitava Dasgupta1st ed.Hoboken, N.J. John Wiley & Sonsc20121 online resource (467 p.)Description based upon print version of record.9781118149652 1118149653 Includes bibliographical references and index.An introduction to tests performed in toxicology laboratories and methodologies available for such testings -- Challenges in drugs of abuse testing -- False positive results in immunoassays for drugs of abuse testing -- True positive drugs of abuse test results due to prescription and non-prescription drugs -- When toxicology report is negative in a suspected overdosed patient : the world of designer drugs -- Abuse of magic mushroom, peyote cactus and solvent : no readily available laboratory tests -- False positive alcohol tests using breath analyzers and automated analyzers -- Role of laboratory in detecting other poisoning including pesticides, ethylene glycol, and methanol -- Poisoning with warfarin and superwarfarin : what laboratory can do? -- Plant poisoning and clinical laboratory -- Sources of erroneous results in therapeutic drug monitoring due to pre-analytical errors, high bilirubin, hemolysis, and heterophilic antibody -- Interferences in immunoassays used for digoxin monitoring -- Interferences in immunoassays used for monitoring anticonvulsants and usefulness of monitoring free anticonvulsants in certain patients -- Interferences in immunoassays used for monitoring tricyclic antidepressant -- Therapeutic drug monitoring of immunosuppressant drugs : limitations of immunoassays and need for chromatographic methods -- Effect of drug-herb interactions on therapeutic drug monitoring -- Pharmacogenomics and toxicology laboratory -- Approaches for eliminating interference/discordant specimen in therapeutic drug monitoring and drugs of abuse testing. The tools for detecting false positives, false negatives, and interference in interactions when testing and monitoring therapeutic drug use For physicians monitoring a patient's progress, efficacy of treatment is often linked to a patient's response to medication. Determining whether a patient is taking the prescribed amount, the drug or dosage is effective, or the prescribed medication is interacting with other drugs can be determined through drug testing. Written as a guide for toxicologists, chemists, and health professionals involved in patient care, Resolving Erroneous Drug monitoringDrug monitoring.615.7/040724Dasgupta Amitava1958-867120MiAaPQMiAaPQMiAaPQBOOK9910807170403321Resolving erroneous reports in toxicology and therapeutic drug monitoring4080249UNINA